The report, not made public, was commissioned by the main US pharmaceutical lobby, the Pharmaceutical Research and ...

Organon (OGN) closed at $12.20 in the latest trading session, marking a +0.66% move from the prior day. The stock trailed the S&P 500, which registered a daily gain of 0.74%. Elsewhere, the Dow gained ...

Healthcare leaders are confident in the potential of AI to transform the industry but are adopting the technology slowly, management consulting firm Bain & Co. found. Here are seven things to know ...

Champions Oncology, Inc.’s CSBR share price has surged by 7.56%, which has investors questioning if this is right time to ...

Prices of medication and other costs could increase by as much as 12.9 percent if the tariffs are put in place ...

Amgen Inc. will invest $900 million to expand an Ohio manufacturing facility, the latest drug company to promise increased US ...

Emzor Pharmaceutical Industries Limited, a top industry player, has restated its commitment to supporting efforts curb the ...

Stay informed with the latest breaking news from Afghanistan. Politics, business, sports, and culture updates in English – ...

The United States has a $115.5 billion trade deficit in pharmaceutical products, which the Trump administration has suggested ...

Despite the decision being a win for Novo Nordisk, the compounded drugs sector is far too complex for this to be a final ...

In the high-stakes world of pharmaceutical manufcturing, where regulatory compliance meets razor-thin margins and patient safety, one industry leader is redefining what Lean transformation means in ...

Report warns 25% pharma tariff could add $51 billion to US drug costs, impacting prices and global competitiveness.